Enzyme inhibitor – Biasly

Enzyme inhibitor Follow

Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024 - Aprea Therapeutics (NASDAQ:APRE)

Merck & Co.

Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24,...

Benzinga
Jun 21, 2024

Center